The COVID-19 pandemic continues to have significant health, human, social and economic impacts on South African (SA) society. COVID-19 vaccines currently offer the most promising means to safeguard personal health, protect the most vulnerable populations, reopen social and economic life, and potentially achieve population health and safety through immunity.1 However, the success of COVID-19 vaccines depends on high levels of uptake. Supply-side factors related to vaccine availability, infrastructure and accessibility all pose significant challenges to optimal uptake in SA.2,3 Vaccine hesitancy " which involves varying levels of doubt, indecision, uncertainty or mistrust about vaccination4 " is an additional challenge. Vaccine hesitancy poses significant risks, not only for the hesitant individual, but also for the wider community.
Human Sciences Research Council (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: